FIELD: medicine. SUBSTANCE: solution contains at least one osmotically active ingredient selected from acetylated amino sugar, deacetylated amino sugar, or their combinations. The agent is taken as monomer or oligomer having 2 to 12 carbohydrate links. N- acetylgalactosamine, N-acetylglucosamine, N-acetylmannosamine, glucosamine, galactosamine, mannosamine are usable as the agent. The solution optionally contains electrolytes like Na, Cl, Ca, Mg, lactate, malate, acetate, succinate, or their combinations. It has pH of 5.0-7.4. Method for performing peritoneal analysis involves introducing the solution into the peritoneal cavity. Method for treating the patient on the occasion of renal insufficiency involves introducing the solution into the peritoneal cavity of the patient. EFFECT: improved biocompatibility properties; avoided morphological or functional disorders of the peritoneal membrane; prolonged period of treatment. 28 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
SOLUTION FOR PERITONEAL DIALYSIS | 2014 |
|
RU2567043C1 |
PERITONEAL THERAPEUTIC LIQUID | 2016 |
|
RU2718908C2 |
PERITONEAL DIALYSATE | 2007 |
|
RU2429822C1 |
THERAPEUTIC CARBOHYDRATES FOR TREATING RESPIRATORY DISEASES | 2010 |
|
RU2539899C2 |
SORBENT FOR DIALYSIS DEVICE AND DIALYSIS SYSTEM | 2017 |
|
RU2785326C2 |
BIOSYNTHETIC HEPARIN | 2017 |
|
RU2760706C2 |
CONCENTRATE | 2011 |
|
RU2613894C2 |
PROCESS OF PRODUCTION OF O-ACYLATED GLUCOS-AMINOGLYCANES | 0 |
|
SU1831487A3 |
METHOD FOR SYNTHESIS OF MODIFIED HYALURONAN AND APPLICATION THEREOF IN MEDICINE, INCLUDING IN ENDOPROSTHETICS | 2019 |
|
RU2750000C1 |
DERIVATIVES OF PROPIONIC ACID (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FOR SELECTIVE INHIBITION OF αβ-INTEGRIN BINDING | 2000 |
|
RU2255933C9 |
Authors
Dates
2000-11-10—Published
1996-08-09—Filed